Eikon Therapeutics Inc.
01/30/2026 | Press release | Archived content
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:30 P.M. |
| Form: | S-1 | ||||||
|
|||||||
Eikon Therapeutics Inc. published this content on January 30, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 02, 2026 at 11:08 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]